Related Experiment Video
Updated: Jan 19, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Two Rare Complications in One Patient: Acquired von Willebrand Syndrome Associated with Intracranial Plasmacytoma
1Hematology Department, University Hospital of Nancy, 5 Rue du Morvan, 54500 Vandoeuvre les Nancy, France.
Abstract:
Here, we describe a rare case of acquired von Willebrand syndrome (VWS) associated with intracranial plasmacytoma. The literature includes reports of a few cases of plasmacytoma with central nervous involvement, but none of them with acquired VWS. Diagnosis was made based on a stereotaxic intracerebral biopsy. During this biopsy, a ventriculoperitoneal shunt was established, which was complicated with abnormal bleeding. Subsequent hemostasis assessment related to hemopathy revealed acquired von Willebrand disease. The patient received induction therapy with bortezomib, thalidomide, and dexamethasone (VTD), followed by high-dose melphalan chemotherapy and autologous stem cell transplantation, and then VTD consolidation, and finally maintenance with lenalidomide. Our patient currently remains in very good partial response without neurological symptoms after 4 months of maintenance. The patient is free of progression 14 months after their original presentation.
Insights
This report details a rare case of acquired von Willebrand syndrome (VWS) linked to intracranial plasmacytoma. Effective treatment involved chemotherapy and stem cell transplant, leading to a positive patient outcome.
Area of Science:
- Neurology
- Hematology
- Oncology
Background:
- Intracranial plasmacytomas are rare central nervous system tumors.
- Acquired von Willebrand syndrome (VWS) is an uncommon bleeding disorder.
Observation:
- A patient presented with symptoms necessitating a stereotaxic intracerebral biopsy for plasmacytoma diagnosis.
- Abnormal bleeding occurred post-biopsy during ventriculoperitoneal shunt placement.
- Hemostasis assessment identified acquired von Willebrand disease.
Findings:
- This is the first reported case of acquired VWS associated with intracranial plasmacytoma.
- The patient achieved a very good partial response with no neurological symptoms after 4 months of maintenance therapy.
- The patient remains progression-free 14 months post-presentation.
Implications:
- Highlights a rare but significant association between intracranial plasmacytoma and acquired VWS.
- Demonstrates the efficacy of a multi-modal treatment approach including VTD chemotherapy, stem cell transplantation, and maintenance therapy.
- Suggests the importance of hemostasis assessment in patients with central nervous system tumors presenting with bleeding complications.
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

